Parexel expands CRA training program; Recipharm inks a 10-year deal;

> Parexel International ($PRXL) has expanded its academy program in Japan, partnering with Kyoto Pharmaceutical University to train future clinical researchers. More

> BioClinica added health IT outfit Vitrana to its network of eClinical app developers, tapping the company's capabilities in processing adverse event reports. Item

> Recipharm signed a 10-year contract extension with South Korean drugmaker Daewoong worth €25 million ($27 million). Release

Suggested Articles

Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.

The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.

Boehringer Ingelheim and MD Anderson Cancer Center have joined forces to create a “virtual” R&D hub so the pair can work on cancer drugs.